Patents by Inventor Taher Nassar

Taher Nassar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DERIVATIVES OF TAXOL AND CLOSELY RELATED COMPOUNDS
    Publication number: 20100298421
    Abstract: A cytotoxic composition in which two moieties are conjugated covalently. A first moiety is a tax moiety, selected from the group consisting of taxanes, taxane derivatives, and or other closely relative compounds. A second moiety is an acid moiety selected from the group consisting of lipoic acid, acetylcysteine, compounds having an acidic group.
    Type: Application
    Filed: January 16, 2009
    Publication date: November 25, 2010
    Inventors: Anwar Rayan, Taher Nassar
  • NOVEL CONJUGATES OF POLYUNSATURATED FATTY ACIDS WITH AMINES AND THERAPEUTIC USES THEREOF
    Publication number: 20100144827
    Abstract: The present application discloses conjugates comprising an aminic moiety covalently linked to a hydrophobic moiety, through an amidic bond, which are selective inhibitors of COX-2 enzyme and can be beneficially used in the treatment of various inflammatory disease or disorder and cancer.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 10, 2010
    Applicant: MedWell Laboratories Ltd. c/o NGT Technological Incubator
    Inventors: Taher Nassar, Raiyn Nureldin, Anwar Rayan
  • Drug delivery system
    Publication number: 20050180997
    Abstract: A combination product comprising a positive oil in water emulsion wherein said emulsion comprises a compound presenting free NH2 groups, at its natural state, at the oil-water interface, and an antibody, wherein said compound is linked to said antibody by a heterobifunctional linker, linking said NH2 groups to SH groups on the antibody hinge region.
    Type: Application
    Filed: February 27, 2004
    Publication date: August 18, 2005
    Inventors: Simon Benita, Danny Goldstein, Taher Nassar, Ola Sader, Alain Razafindratsita, Gregory Lambert, Jean Kadouche
  • Controlled release oral drug delivery system
    Patent number: 6692766
    Abstract: The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the gastrointestinal tract comprising a hydrogel-forming polymer selected from the group consisting of (a) polymers which are themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inbihiting degradation of said drug by intestinal enzymes; and (b) polymers which are not themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inhibiting degradation of said drug by intestinal enzymes; wherein when the matrix comprises a polymer belonging to group (b) the delivery system further comprises an agent which enhances absorption of said drug across the intestinal mucosal tissues and/or an agent which inhibits degradation of said drug by intestinal enzymes and when the matrix comprises a polymer belon
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: February 17, 2004
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem
    Inventors: Abraham Rubinstein, Raphael Radai, Michael Friedman, Boaz Tirosh, Muhammad Baluom, Taher Nassar